Compare LODE & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LODE | ANIK |
|---|---|---|
| Founded | 2008 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.1M | 134.8M |
| IPO Year | N/A | 1993 |
| Metric | LODE | ANIK |
|---|---|---|
| Price | $2.77 | $10.42 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $4.00 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 3.0M | 154.1K |
| Earning Date | 03-05-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,778,445.00 | ★ $112,806,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,798.62 | $4.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 48.99 | 30.55 |
| 52 Week Low | $1.67 | $7.87 |
| 52 Week High | $4.80 | $18.35 |
| Indicator | LODE | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 39.84 | 61.88 |
| Support Level | $2.62 | $9.88 |
| Resistance Level | $2.95 | $10.62 |
| Average True Range (ATR) | 0.24 | 0.41 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 31.92 | 72.68 |
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.